1	¿	¿	Fia	-	-	442-443	675_QUEST_clinical_caseMIR	SENT1	-	-
2	Cúal	cúal	RG	-	-	443-447	675_QUEST_clinical_caseMIR	SENT1	-	-
3	es	ser	VSIP3S0	-	-	448-450	675_QUEST_clinical_caseMIR	SENT1	-	-
4	el	el	DA0MS0	-	-	451-453	675_QUEST_clinical_caseMIR	SENT1	-	-
5	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	454-465	675_QUEST_clinical_caseMIR	SENT1	-	-
6	más	más	RG	C0205172	calificador	466-469	675_QUEST_clinical_caseMIR	SENT1	-	-
7	apropiado	apropiar	VMP00SM	-	-	470-479	675_QUEST_clinical_caseMIR	SENT1	-	-
8	?	?	Fit	-	-	479-480	675_QUEST_clinical_caseMIR	SENT1	-	-
9	:	:	Fd	-	-	480-481	675_QUEST_clinical_caseMIR	SENT1	-	-
10	Una	Una		C0205447_1	calificador_1	0-3	675_QUEST_clinical_caseMIR	SENT1	-	-
11	mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	4-9	675_QUEST_clinical_caseMIR	SENT1	-	-
12	de	de	SPS00	C0332285	atributo	10-12	675_QUEST_clinical_caseMIR	SENT1	-	-
13	83	83		-	-	13-15	675_QUEST_clinical_caseMIR	SENT1	-	-
14	años	año	NCMP000	C0439234	calificador	16-20	675_QUEST_clinical_caseMIR	SENT1	-	-
15	alérgica	alérgico	AQ0FS0	-	-	21-29	675_QUEST_clinical_caseMIR	SENT1	-	-
16	a	a	SPS00	-	-	30-31	675_QUEST_clinical_caseMIR	SENT1	-	-
17	betalactámicos	betalactámico	NC00SC0	C0282215	sustancia	32-46	675_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
18	ingresa	ingresar	VMIP3S0	-	-	47-54	675_QUEST_clinical_caseMIR	SENT1	-	-
19	por	por	SPS00	C0678226	atributo	55-58	675_QUEST_clinical_caseMIR	SENT1	-	-
20	pielonefritis	pielonefritis	NC00SC0	C0520575_1	trastorno_1	59-72	675_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
21	aguda	agudo	AQ0FS0	C0520575_2	trastorno_2	73-78	675_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
22	y	y	CC	C1706368	calificador	79-80	675_QUEST_clinical_caseMIR	SENT1	-	-
23	vómitos	vómito	NCMP000	C0042963_1	trastorno_1	81-88	675_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
24	.	.	Fp	-	-	88-89	675_QUEST_clinical_caseMIR	SENT1	-	-

1	Toma	tomar	VMIP3S0	C1515187	calificador	90-94	675_QUEST_clinical_caseMIR	SENT2	-	-
2	amiodarona	amiodarona	NC00SC0	C0002598	producto#sustancia	95-105	675_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
3	desde	desde	SPS00	-	-	106-111	675_QUEST_clinical_caseMIR	SENT2	-	-
4	hace	hacer	VMIP3S0	-	-	112-116	675_QUEST_clinical_caseMIR	SENT2	-	-
5	3	3		-	-	117-118	675_QUEST_clinical_caseMIR	SENT2	-	-
6	años	año	NCMP000	C0439234	calificador	119-123	675_QUEST_clinical_caseMIR	SENT2	-	-
7	por	por	SPS00	C0678226	atributo	124-127	675_QUEST_clinical_caseMIR	SENT2	-	-
8	fibrilación	fibrilación	NCFS000	C0235480_1	trastorno_1	128-139	675_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
9	auricular	auricular	NCMS000	C0235480_2	trastorno_2	140-149	675_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
10	paroxística	paroxístico	AQ0FS0	C0235480_3	trastorno_3	150-161	675_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
11	.	.	Fp	-	-	161-162	675_QUEST_clinical_caseMIR	SENT2	-	-

1	Al	al	SP+DA	-	-	163-165	675_QUEST_clinical_caseMIR	SENT3	-	-
2	ingreso	ingreso	NCMS000	-	-	166-173	675_QUEST_clinical_caseMIR	SENT3	-	-
3	se	se	P00CN000	-	-	174-176	675_QUEST_clinical_caseMIR	SENT3	-	-
4	pauta	pautar	VMIP3S0	-	-	177-182	675_QUEST_clinical_caseMIR	SENT3	-	-
5	levofloxacino	levofloxacino	NC00SC0	C0282386	producto#sustancia	183-196	675_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
6	y	y	CC	C1706368	calificador	197-198	675_QUEST_clinical_caseMIR	SENT3	-	-
7	metoclopramida	metoclopramida	NC00SC0	C0025853	sustancia	199-213	675_QUEST_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
8	.	.	Fp	-	-	213-214	675_QUEST_clinical_caseMIR	SENT3	-	-

1	Por	por	SPS00	C0678226	atributo	215-218	675_QUEST_clinical_caseMIR	SENT4	-	-
2	agitación	agitación	NCFS000	C0085631	hallazgo	219-228	675_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
3	nocturna	nocturno	AQ0FS0	C0240526	calificador	229-237	675_QUEST_clinical_caseMIR	SENT4	B-Calificador	-
4	se	se	P00CN000	-	-	238-240	675_QUEST_clinical_caseMIR	SENT4	-	-
5	añade	añadir	VMIP3S0	-	-	241-246	675_QUEST_clinical_caseMIR	SENT4	-	-
6	haloperidol	haloperidol	NC00SC0	C0018546	sustancia	247-258	675_QUEST_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
7	.	.	Fp	-	-	258-259	675_QUEST_clinical_caseMIR	SENT4	-	-

1	Al	al	SP+DA	-	-	260-262	675_QUEST_clinical_caseMIR	SENT5	-	-
2	6º	6º	Z	-	-	263-265	675_QUEST_clinical_caseMIR	SENT5	-	-
3	día	d	NCMS000	-	-	266-269	675_QUEST_clinical_caseMIR	SENT5	-	-
4	sufre	sufrir	VMIP3S0	-	-	270-275	675_QUEST_clinical_caseMIR	SENT5	-	-
5	un	un		C0205447_1	calificador_1	276-278	675_QUEST_clinical_caseMIR	SENT5	-	-
6	síncope	síncope	NCMS000	C0039070#C0332521_1	trastorno#anomalía_morfológica#hallazgo_1	279-286	675_QUEST_clinical_caseMIR	SENT5	B-Grp_Enfermedad	-
7	del	del	SP+DA	-	-	287-290	675_QUEST_clinical_caseMIR	SENT5	-	-
8	que	que	PR0CN000	-	-	291-294	675_QUEST_clinical_caseMIR	SENT5	-	-
9	se	se	P00CN000	-	-	295-297	675_QUEST_clinical_caseMIR	SENT5	-	-
10	recupera	recuperar	VMIP3S0	-	-	298-306	675_QUEST_clinical_caseMIR	SENT5	-	-
11	a	a	SPS00	-	-	307-308	675_QUEST_clinical_caseMIR	SENT5	-	-
12	los	el	DA0MP0	-	-	309-312	675_QUEST_clinical_caseMIR	SENT5	-	-
13	pocos	poco	DI0MP0	C0700321#C1282918	-	313-318	675_QUEST_clinical_caseMIR	SENT5	-	-
14	segundos	segundo	NCMP000	C0205436	calificador	319-327	675_QUEST_clinical_caseMIR	SENT5	-	-
15	.	.	Fp	-	-	327-328	675_QUEST_clinical_caseMIR	SENT5	-	-

